Compare Definium Therapeutics Inc. Common Shares (DFTX) vs NOV Inc. Common Stock (NOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs NOV Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.54 (market cap $4.59B), while NOV Inc. Common Stock trades at $18.96 (market cap $6.77B). The key difference: NOV Inc. Common Stock is the larger of the two by market cap, and NOV Inc. Common Stock pays a 1.9% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and NOV Inc. Common Stock for 1 Days on average.
| DFTX | NOV | |
|---|---|---|
Market Cap | $4.59B | $6.77B |
Volume | 2,103,937 | 3,592,724 |
Sector | Health | Energy |
52-Week High | $48.45 | $21.71 |
52-Week Low | $10.68 | $12.31 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $3.55B | $7.93B |
Dividend Yield | — | 1.9% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →
